SCHEMBL3560484

SCHEMBL3560484

COc1ccc(NCc2ccc3oc(C(=O)O)cc3c2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 1/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 1/20 0.52
DHFR P00374 2/20 0.52
HDAC1 Q13547 5/20 0.51
HDAC2 Q92769 3/20 0.51
POLB P06746 2/20 0.50
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
KDM4E B2RXH2 2/20 0.49
GAA P10253 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
HIF1A Q16665 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064412 0.91 L3MBTL1 (0.53) L3MBTL1MEN1RAB9AKMT2ADHFR
SCHEMBL21697974 0.91 L3MBTL1 (0.53) L3MBTL1MEN1RAB9AKMT2ADHFR
SCHEMBL5583473 0.88 LMNA (0.56) LMNATP53L3MBTL1DHFRHDAC1
SCHEMBL3558423 0.84 TUBB4A (0.54) LMNATP53MEN1KMT2ADHFR
SCHEMBL1065598 0.82 HDAC1 (0.71) TP53L3MBTL1MEN1RAB9AKMT2A
SCHEMBL17182548 0.81 ALDH1A1 (0.54) LMNATP53L3MBTL1MEN1KMT2A
SCHEMBL5583428 0.81 HIF1A (0.58) LMNATP53MEN1KMT2AKDM4E
SCHEMBL1064897 0.80 NR1H4 (0.67) L3MBTL1MEN1RAB9AKMT2AHDAC1
SCHEMBL17182504 0.80 FFAR1 (0.51) LMNATP53MEN1RAB9AKMT2A
SCHEMBL5583397 0.79 DHFR (0.53) LMNATP53MEN1KMT2ADHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838520-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2010-11-23 US disclosed
US-7595343-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2009-09-29 US disclosed
US-20060058298-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2006-03-16 US disclosed
US-20050288282-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2005-12-29 US disclosed
US-6897220-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2005-05-24 US disclosed
US-20040142953-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2004-07-22 US disclosed
US-20040106599-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288282-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 LMNA 1922/4885TP53 575/4885L3MBTL1 1291/4885
US-20040106599-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 LMNA 1922/4885TP53 575/4885L3MBTL1 1291/4885
US-20060058298-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 LMNA 1922/4885TP53 575/4885L3MBTL1 1291/4885
US-20040142953-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 LMNA 1922/4885TP53 575/4885L3MBTL1 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.